Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Verastem Inc (NQ: VSTM )

1.480 USD -0.050 (-3.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,788,051
Open 1.530
Bid (Size) 1.450 (9)
Ask (Size) 1.510 (32)
Prev. Close 1.530
Today's Range 1.480 - 1.575
52wk Range 1.480 - 4.935
Shares Outstanding 182,185,991
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone of Therapy for RAS Pathway-Driven Cancers
Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today outlined key strategic priorities and upcoming catalysts to support... 
From Business Wire News Releases
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the grant of options to purchase 1,625 shares of its... 
From Business Wire News Releases

Performance

YTD
-29.52%
-29.52%
1 Month
-33.63%
-33.63%
3 Month
-42.86%
-42.86%
6 Month
-55.42%
-55.42%
1 Year
-30.84%
-30.84%

More News

Read More
Verastem Oncology to Participate in Upcoming Investor Conferences
From Business Wire News Releases
Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer
From Business Wire News Releases
Verastem Oncology to Present at the Jefferies London Healthcare Conference
From Business Wire News Releases
Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
From Business Wire News Releases
Verastem Oncology Appoints Michelle Robertson to Board of Directors
From Business Wire News Releases
Interesting VSTM Put Options For February 2022
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
Tags ALNY FDA NVS
From Benzinga
Analysts Anticipate 95% Gains Ahead For XBI
Tags ETFs
From ETF Channel
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags BLUE ACER CASI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.